.
MergerLinks Header Logo

Announced

iMedX acquired Prevalent and Axcension.

Financials

Edit Data
Transaction Value-
Consideration Type-
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-

Tags

Edit

Private

Completed

Health Care Services

health care

health care organization

United States

Acquisition

Single Bidder

Synopsis

Edit

iMedX, an international leader in revenue cycle management, medical documentation, and health information solutions has successfully completed the acquisition of Prevalent and Axcension. Financial terms were not disclosed. Both Axcension and Prevalent are proven providers of cutting-edge healthcare analytics and revenue cycle management consulting services. "A comprehensive analytics platform will be a vital part of every provider's RCM workflow in the coming years, which is why these acquisitions are so important to us. Having thorough insight into billing operations will be a necessity as we continue to maximize reimbursement for our clients in an everchanging regulatory environment." Christopher Foley, Chairman and CEO of iMedX.

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US